⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of LSK Global Pharma Services and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
LSK Global Pharma Services
↗Seoul, South Korea
LSK Global Pharma Services (LSK Global PS) is a leading full-service Contract Research Organization (CRO) headquartered in Seoul, South Korea. Established in 2000, the company provides end-to-end clinical research solutions, including consulting, regulatory affairs, clinical operations, data management, biostatistics, and pharmacovigilance for pharmaceutical and biotech companies.
As the first Korean CRO to successfully conduct global clinical trials, LSK Global PS specializes in bridging local Korean drug development with global markets. The company has extensive experience across various therapeutic areas, including oncology, cardiovascular disease, and endocrinology, and is committed to maintaining global quality standards in compliance with ICH-GCP guidelines.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Founded:2000
Ownership:private
Status:operating
FUNDING
Investors:Westat
PIPELINE
Active Trials:190
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Medidata Solutions (Technology partner), Veeva Systems (Technology partner), Asia CRO Alliance (ACA)
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Young-Jack Lee - President & CEO
Dae Hee Shin - Senior Vice President
LINKS
Website:lskglobal.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with LSK Global Pharma Services. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.